These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 14965307)

  • 1. NKT cell-stimulating synthetic glycolipids as potential therapeutics for autoimmune disease.
    Yamamura T; Miyamoto K; Illés Z; Pál E; Araki M; Miyake S
    Curr Top Med Chem; 2004; 4(5):561-7. PubMed ID: 14965307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic potential of glycolipid ligands for natural killer (NK) T cells in the suppression of autoimmune diseases.
    Miyake S; Yamamura T
    Curr Drug Targets Immune Endocr Metabol Disord; 2005 Sep; 5(3):315-22. PubMed ID: 16178791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potent immune-modulating and anticancer effects of NKT cell stimulatory glycolipids.
    Chang YJ; Huang JR; Tsai YC; Hung JT; Wu D; Fujio M; Wong CH; Yu AL
    Proc Natl Acad Sci U S A; 2007 Jun; 104(25):10299-304. PubMed ID: 17566107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative and qualitative differences in the in vivo response of NKT cells to distinct alpha- and beta-anomeric glycolipids.
    Parekh VV; Singh AK; Wilson MT; Olivares-Villagómez D; Bezbradica JS; Inazawa H; Ehara H; Sakai T; Serizawa I; Wu L; Wang CR; Joyce S; Van Kaer L
    J Immunol; 2004 Sep; 173(6):3693-706. PubMed ID: 15356115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic glycolipid ligands for human iNKT cells as potential therapeutic agents for immunotherapy.
    Araki M; Miyake S; Yamamura T
    Curr Med Chem; 2008; 15(23):2337-45. PubMed ID: 18855664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural killer T cells as targets for therapeutic intervention in autoimmune diseases.
    Wilson MT; Van Kaer L
    Curr Pharm Des; 2003; 9(3):201-20. PubMed ID: 12570826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells.
    Miyamoto K; Miyake S; Yamamura T
    Nature; 2001 Oct; 413(6855):531-4. PubMed ID: 11586362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of invariant natural killer T (iNKT) cells in systemic lupus erythematosus.
    Godó M; Sessler T; Hamar P
    Curr Med Chem; 2008; 15(18):1778-87. PubMed ID: 18691038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A subset of NKT cells that lacks the NK1.1 marker, expresses CD1d molecules, and autopresents the alpha-galactosylceramide antigen.
    Hameg A; Apostolou I; Leite-De-Moraes M; Gombert JM; Garcia C; Koezuka Y; Bach JF; Herbelin A
    J Immunol; 2000 Nov; 165(9):4917-26. PubMed ID: 11046017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tailored design of NKT-stimulatory glycolipids for polarization of immune responses.
    Hung JT; Huang JR; Yu AL
    J Biomed Sci; 2017 Mar; 24(1):22. PubMed ID: 28335781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective ability of mouse CD1 to present glycolipids: alpha-galactosylceramide specifically stimulates V alpha 14+ NK T lymphocytes.
    Burdin N; Brossay L; Koezuka Y; Smiley ST; Grusby MJ; Gui M; Taniguchi M; Hayakawa K; Kronenberg M
    J Immunol; 1998 Oct; 161(7):3271-81. PubMed ID: 9759842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presentation of alpha-galactosylceramide by murine CD1d to natural killer T cells is facilitated by plasma membrane glycolipid rafts.
    Lang GA; Maltsev SD; Besra GS; Lang ML
    Immunology; 2004 Jul; 112(3):386-96. PubMed ID: 15196206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis.
    Singh AK; Wilson MT; Hong S; Olivares-Villagómez D; Du C; Stanic AK; Joyce S; Sriram S; Koezuka Y; Van Kaer L
    J Exp Med; 2001 Dec; 194(12):1801-11. PubMed ID: 11748281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycolipid alpha-C-galactosylceramide is a distinct inducer of dendritic cell function during innate and adaptive immune responses of mice.
    Fujii S; Shimizu K; Hemmi H; Fukui M; Bonito AJ; Chen G; Franck RW; Tsuji M; Steinman RM
    Proc Natl Acad Sci U S A; 2006 Jul; 103(30):11252-7. PubMed ID: 16844772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysfunction of T cell receptor AV24AJ18+, BV11+ double-negative regulatory natural killer T cells in autoimmune diseases.
    Kojo S; Adachi Y; Keino H; Taniguchi M; Sumida T
    Arthritis Rheum; 2001 May; 44(5):1127-38. PubMed ID: 11352245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human invariant V alpha 24-J alpha Q TCR supports the development of CD1d-dependent NK1.1+ and NK1.1- T cells in transgenic mice.
    Capone M; Cantarella D; Schümann J; Naidenko OV; Garavaglia C; Beermann F; Kronenberg M; Dellabona P; MacDonald HR; Casorati G
    J Immunol; 2003 Mar; 170(5):2390-8. PubMed ID: 12594262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacterial glycolipids and analogs as antigens for CD1d-restricted NKT cells.
    Wu D; Xing GW; Poles MA; Horowitz A; Kinjo Y; Sullivan B; Bodmer-Narkevitch V; Plettenburg O; Kronenberg M; Tsuji M; Ho DD; Wong CH
    Proc Natl Acad Sci U S A; 2005 Feb; 102(5):1351-6. PubMed ID: 15665086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapeutic potential for ceramide-based activators of iNKT cells.
    Berkers CR; Ovaa H
    Trends Pharmacol Sci; 2005 May; 26(5):252-7. PubMed ID: 15860372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The complementarity determining region 2 of BV8S2 (V beta 8.2) contributes to antigen recognition by rat invariant NKT cell TCR.
    Pyz E; Naidenko O; Miyake S; Yamamura T; Berberich I; Cardell S; Kronenberg M; Herrmann T
    J Immunol; 2006 Jun; 176(12):7447-55. PubMed ID: 16751390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of immune responses by CD1d-restricted natural killer T cells.
    Van Kaer L
    Immunol Res; 2004; 30(2):139-53. PubMed ID: 15477656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.